Last edition
News about "litifilimab"
Royalty Pharma Signs R&D Funding Agreement with Biogen
Litifilimab is currently in Phase 3 trials for both SLE and CLE with results expected between 2026 and 2027.
Litifilimab | 13/02/2025 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members